Art Zbrozek

582 total citations
18 papers, 481 citations indexed

About

Art Zbrozek is a scholar working on Immunology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Art Zbrozek has authored 18 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 4 papers in Public Health, Environmental and Occupational Health and 4 papers in Hematology. Recurrent topics in Art Zbrozek's work include Psoriasis: Treatment and Pathogenesis (5 papers), Dermatology and Skin Diseases (3 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). Art Zbrozek is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (5 papers), Dermatology and Skin Diseases (3 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). Art Zbrozek collaborates with scholars based in United States, Germany and United Kingdom. Art Zbrozek's co-authors include Linus Jönsson, Anders Wimo, Glenn Magee, Jason Karlawish, Chen‐Yen Lin, Bruce Kinosian, Henry A. Glick, Robert Boggs, C. Molta and Ron Pedersen and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Allergy and Clinical Immunology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Art Zbrozek

17 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Art Zbrozek United States	12	137	122	112	108	56	18	481
Hilary H. Colwell United States	17	107 0.8×	76 0.6×	58 0.5×	91 0.8×	17 0.3×	39	848
Jiat Ling Poon United States	19	82 0.6×	67 0.5×	109 1.0×	49 0.5×	9 0.2×	73	974
Robert Offer Canada	6	33 0.2×	74 0.6×	211 1.9×	74 0.7×	34 0.6×	6	582
Martinsixtus Ezejimofor United Kingdom	11	50 0.4×	41 0.3×	52 0.5×	177 1.6×	11 0.2×	15	547
C Bakker Netherlands	15	265 1.9×	107 0.9×	212 1.9×	46 0.4×	17 0.3×	15	696
Vanessa Cox United States	12	109 0.8×	158 1.3×	40 0.4×	33 0.3×	21 0.4×	12	683
SP McKenna United States	9	106 0.8×	62 0.5×	72 0.6×	9 0.1×	19 0.3×	23	468
Shayan Shirazian United States	12	76 0.6×	46 0.4×	32 0.3×	107 1.0×	6 0.1×	26	740
Mark Perry United Kingdom	13	20 0.1×	140 1.1×	40 0.4×	45 0.4×	19 0.3×	26	617
Selina Chow United States	15	53 0.4×	116 1.0×	31 0.3×	19 0.2×	13 0.2×	54	700

Countries citing papers authored by Art Zbrozek

Since Specialization

Citations

This map shows the geographic impact of Art Zbrozek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Art Zbrozek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Art Zbrozek more than expected).

Fields of papers citing papers by Art Zbrozek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Art Zbrozek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Art Zbrozek. The network helps show where Art Zbrozek may publish in the future.

Co-authorship network of co-authors of Art Zbrozek

This figure shows the co-authorship network connecting the top 25 collaborators of Art Zbrozek. A scholar is included among the top collaborators of Art Zbrozek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Art Zbrozek. Art Zbrozek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Weycker, Derek, et al.. (2024). DRUG PATTERNS, CLINICAL OUTCOMES, AND ECONOMIC COSTS AMONG HEREDITARY ANGIOEDEMA PATIENTS INITIATING LONG-TERM PROPHYLAXIS. Annals of Allergy Asthma & Immunology. 133(6). S26–S26.

Wu, Jashin J., Chen‐Yen Lin, Orin M. Goldblum, et al.. (2020). Efficacious psoriasis treatment improves patients' work productivity. Journal of the European Academy of Dermatology and Venereology. 34(10). e593–e596. 2 indexed citations

Tillett, William, et al.. (2019). A Threshold of Meaning for Work Disability Improvement in Psoriatic Arthritis Measured by the Work Productivity and Activity Impairment Questionnaire. Rheumatology and Therapy. 6(3). 379–391. 32 indexed citations

Wu, Jashin J., Chen‐Yen Lin, Orin M. Goldblum, et al.. (2018). Minimal clinically important difference (MCID) for work productivity and activity impairment (WPAI) questionnaire in psoriasis patients. Journal of the European Academy of Dermatology and Venereology. 33(2). 318–324. 32 indexed citations

Murage, Mwangi J., Amanda H. Anderson, Deborah Casso, et al.. (2018). Treatment patterns, adherence, and persistence among psoriasis patients treated with biologics in a real-world setting, overall and by disease severity. Journal of Dermatological Treatment. 30(2). 141–149. 25 indexed citations

Zbrozek, Art, et al.. (2015). Evidence of Wear-Off Effect from Ig Infusion Therapy in Routine Clinical Practice. Journal of Allergy and Clinical Immunology. 135(2). AB88–AB88. 2 indexed citations

Menzin, Joseph, et al.. (2014). Economic impact of infections among patients with primary immunodeficiency disease receiving IVIG therapy. ClinicoEconomics and Outcomes Research. 6. 297–297. 16 indexed citations

Magee, Glenn & Art Zbrozek. (2013). Fluid overload is associated with increases in length of stay and hospital costs: pooled analysis of data from more than 600 US hospitals. ClinicoEconomics and Outcomes Research. 5. 289–289. 44 indexed citations

Magee, Glenn, et al.. (2013). Analysis of Inpatient Use of Fresh Frozen Plasma and Other Therapies and Associated Outcomes in Patients with Major Bleeds from Vitamin K Antagonism. Clinical Therapeutics. 35(9). 1432–1443. 10 indexed citations

10.

Panahloo, Zoya, Thomas Machnig, & Art Zbrozek. (2013). Comparative Economics of On-Demand Treatment Options Approved in the United Kingdom for Hereditary Angioedema. Journal of Allergy and Clinical Immunology. 131(2). AB33–AB33. 1 indexed citations

11.

Gniadecki, Robert, Deborah Robertson, C. Molta, et al.. (2011). Self‐reported health outcomes in patients with psoriasis and psoriatic arthritis randomized to two etanercept regimens. Journal of the European Academy of Dermatology and Venereology. 26(11). 1436–1443. 59 indexed citations

12.

Wimo, Anders, Linus Jönsson, & Art Zbrozek. (2010). The resource utilization in dementia (RUD) instrument is valid for assessing informal care time in community-living patients with dementia. The journal of nutrition health & aging. 14(8). 685–690. 121 indexed citations

13.

Karlawish, Jason, et al.. (2008). Preference‐based quality of life in patients with Alzheimer's disease. Alzheimer s & Dementia. 4(3). 193–202. 34 indexed citations

14.

Karlawish, Jason, et al.. (2008). Caregivers' assessments of preference‐based quality of life in Alzheimer's disease. Alzheimer s & Dementia. 4(3). 203–211. 35 indexed citations

15.

Parasuraman, Shreekant, G. R. Hudes, David T. Levy, et al.. (2007). Comparison of quality-adjusted survival in patients with advanced renal cell carcinoma receiving first-line treatment with temsirolimus (TEMSR) or interferon-α (IFN) or the combination of IFN+TEMSR. Journal of Clinical Oncology. 25(18_suppl). 5049–5049. 16 indexed citations

16.

Robinson, Malcolm, et al.. (1994). Mesalamine capsules enhance the quality of life for patients with ulcerative colitis. Alimentary Pharmacology & Therapeutics. 8(1). 27–34. 28 indexed citations

17.

Zbrozek, Art, et al.. (1992). Assessing quality of life in clinical trials. Controlled Clinical Trials. 13(5). 413–413. 21 indexed citations

18.

Zbrozek, Art, et al.. (1988). Compatibility and Stability of Cefazolin Sodium, Clindamycin Phosphate, and Gentamicin Sulfate in Two Intravenous Solutions. Drug Intelligence & Clinical Pharmacy. 22(11). 873–875. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact